tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Debjit Chattopadhyay, 158 are a BUY (90.29%), 17 are a HOLD (9.71%).
Analyst Debjit Chattopadhyay, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 45.78% that have a potential upside of 36.19% achieved within 215 days.
Debjit Chattopadhyay’s has documented 361 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BEAM, Beam Therapeutics at 27-Feb-2025.
Analyst best performing recommendations are on HARP (HARPOON THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $22 was fulfilled within 1 day with a profit of $3.15 (12.52%) receiving and performance score of 125.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$70
$56.3 (410.95%)
$70
24 days ago
(04-Mar-2025)
0/10 (0%)
$59.1 (542.20%)
Buy
$24
$10.3 (75.18%)
$24
2 months 7 days ago
(21-Jan-2025)
1/7 (14.29%)
$9.09 (60.97%)
34
Hold
$20
$6.3 (45.99%)
$6
3 months 9 days ago
(19-Dec-2024)
3/4 (75%)
$4.53 (29.28%)
132
Buy
$32
$18.3 (133.58%)
$37
3 months 12 days ago
(16-Dec-2024)
0/3 (0%)
$14.6 (83.91%)
Hold
$20
$6.3 (45.99%)
$9
3 months 16 days ago
(12-Dec-2024)
3/6 (50%)
$4.94 (32.80%)
99
Which stock is Debjit Chattopadhyay is most bullish on?
Which stock is Debjit Chattopadhyay is most reserved on?
What Year was the first public recommendation made by Debjit Chattopadhyay?
